Interaction of diet and adipose glucocorticoid action in metabolic syndrome
dc.contributor.advisor
Chapman, Karen
en
dc.contributor.advisor
Morton, Nicholas
en
dc.contributor.advisor
Seckl, Jonathan
en
dc.contributor.author
Man, Tak Yung
en
dc.date.accessioned
2011-02-15T10:50:06Z
dc.date.available
2011-02-15T10:50:06Z
dc.date.issued
2010
dc.description.abstract
Metabolic syndrome, a combination of co-associated features including visceral
obesity, dyslipidemia, hypertension, insulin resistance and increased risk of
cardiovascular disease, has reached epidemic levels. Recent evidence has indicated a
pathogenic role for elevated glucocorticoid (GC) levels within adipose tissue
specifically, in obesity. Levels of the glucocorticoid regenerating enzyme 11β-
hydroxysteroid dehydrogenase type 1 (11β-HSD-1), which converts inactive GC into
active forms within cells, are elevated in adipose tissues of obese humans. Transgenic
overexpression of 11β-HSD1 in adipose tissue recapitulates metabolic syndrome in
mice, including visceral obesity, perhaps because glucocorticoid receptor (GR) levels
are higher in visceral than subcutaneous adipose tissue. Therefore, increased adipose
GC action, especially in visceral adipose tissue, might explain the striking similarities
between idiopathic metabolic syndrome and rare Cushing’s syndrome of plasma GC
excess.
One of the major contributors to obesity and metabolic syndrome is
consumption of excessive amounts of dietary fat. Specifically, saturated fats are
associated with obesity and insulin resistance whereas unsaturated fats are reported to
ameliorate some aspects of metabolic disease. Interestingly, chronic high fat feeding in
mice decreases adipose 11β-HSD1 expression, usually without changing expression in
liver. The reduced glucocorticoid regeneration in adipose tissue may ameliorate
metabolic disease. This study investigated the effect of diets enriched in saturated or
unsaturated fats on adipose tissue glucocorticoid action, focusing on 11β-HSD1 and
glucocorticoid receptor expression.
Two studies were carried out, one with pair-feeding (to control low-fat diet) and
one with ab libitum feeding. In both studies, a diet high in saturated fat (stearate)
resulted in significant weight loss whereas a diet consisting of 58% mixed fats resulted
in significant weight gain. In the ab libitium study (but not in pair-fed animals) both
mono-unsaturated (oleic) and poly-unsaturated (safflower) fat-enriched diets induced
weight gain and hyperinsulinaemia and lowered levels of adipose11β-HSD1 when
compared to control diet. These data suggest that diets high in saturated fats elevate
adipose tissue and liver 11β-HSD1 levels which might contribute detrimentally to, or offset, any improvements in the systemic metabolic profile. Conversely, unsaturated fats
cause an adipose-specific down-regulation of 11β-HSD1.
In addition, genetic evidence from human and animal studies has shown that
regulation of glucocorticoid production and receptor density may be an important factor
determining visceral adiposity. The role of adipocyte GR levels in determining visceral
adiposity was investigated. Two types of transgenic mice were generated with altered
GR levels in adipocytes using the adipocyte-specific aP2 promoter; one with a “sense”
rat GR cDNA (2 independent lines; D- and B-FSG) and one with an “anti-sense” rat
GR-cDNA (GR-5). Initial characterisation of D- and B-FSG mice showed expression
of rat GR mRNA in both female and male transgenic mice with D-FSG showing a
higher copy number than B-FSG. In D-FSG transgenic mice, female mice of the F1
generation had greater adipose tissue mass than non-transgenic littermates. A 6-month
high fat study was then carried out on line D-FSG. However, no differences in body
weight, food intake, adipose tissue weight or blood pressure were found in either males
or females. Further investigations of the levels of rat GR mRNA expression within
various adipose tissues showed variable transgene expression between different
generations of B- and D-FSG lines and even between adipose tissues within the same
mouse. In contrast, following 6-months high fat diet, female mice under-expressing GR
within adipose tissues (GR-5) showed a significant reduction in body weight and
subcutaneous adipose tissue weight compared to their non-transgenic littermates. These
data suggest that adipose GR density is an important determinant of visceral adiposity,
in a sex-specific manner.
Collectively, the data in this thesis support a role for GR density and GC
metabolism in adipose tissue as important determinants of adiposity in mice. Drugs that
manipulate these targets are of therapeutic interest.
en
dc.identifier.uri
http://hdl.handle.net/1842/4832
dc.language.iso
en
dc.publisher
The University of Edinburgh
en
dc.relation.hasversion
Tak Yung Man, Lynne Ramage, Adnan Gokcel, Zoi Michailidou, Christopher J. Kenyon, Karen Chapman, Jonathan R. Seckl and Nicholas M. Morton. Dietary Regulation of Peripheral Glucocorticoid Action: Comparison of Saturated and Unsaturated Fats Abstracts, British Endocrine Society, Glasgow 2006
en
dc.relation.hasversion
Tak Yung Man, Lynne Ramage, Adnan Gokcel, Zoi Michailidou, Christopher J. Kenyon, Karen Chapman, Jonathan R. Seckl and Nicholas M. Morton. Saturated Fat Elevates and Unsaturated Fats Down-Regulate Adipose Tissue Glucocorticoid Reamplification Abstracts, The Endocrine Society, Boston 2006
en
dc.subject
glucocorticoid
en
dc.subject
adipose
en
dc.subject
diet
en
dc.title
Interaction of diet and adipose glucocorticoid action in metabolic syndrome
en
dc.type
Thesis or Dissertation
en
dc.type.qualificationlevel
Masters
en
dc.type.qualificationname
MPhil Master of Philosophy
en
This item appears in the following Collection(s)

